Clinical Trials
1
Trial Phases
1 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Study to Evaluate AD04 in Adults With Alcohol Use Disorder (AUD) and Selected Serotonin Transporter Polymorphisms
- Conditions
- Alcohol Use Disorder
- Interventions
- Drug: AD04 (ondansetron)Drug: Matching placeboDevice: Companion Diagnostic for Genetic TestingBehavioral: Brief Psychological Counseling
- First Posted Date
- 2019-09-24
- Last Posted Date
- 2024-04-17
- Lead Sponsor
- Adial Pharmaceuticals
- Target Recruit Count
- 302
- Registration Number
- NCT04101227
- Locations
- 🇧🇬
Mental Health Centre Prof. Dr. Ivan Temkov Burgas EOOD Department for treatment of Emergency Psychiatric conditions, Burgas, Bulgaria
🇧🇬State Psychiatric Hospital, Kardzhali, Bulgaria
🇧🇬UMHAT Dr. Georgi Stranski Second Psychiatric Clinic, Pleven, Bulgaria
News
Adial Pharmaceuticals Receives Milestone Payment as Adovate Launches Phase 1 Trial for Novel Asthma Therapy
Adial Pharmaceuticals has received a six-figure milestone payment from Adovate following the initiation of a Phase 1 clinical trial for ADO-5030, a novel adenosine receptor antagonist targeting asthma.
Adial Pharmaceuticals' AD04 Shows Positive Pharmacokinetics for Alcohol Use Disorder Treatment
Adial Pharmaceuticals' AD04 demonstrated predictable bioavailability and dose proportionality in a recent pharmacokinetics study, AD04-103.